CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis
NASDAQ:BCAL - Nasdaq - US84252A1060 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to BCAL. BCAL was compared to 398 industry peers in the Banks industry. Both the profitability and financial health of BCAL have multiple concerns. BCAL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
BCAL had positive earnings in the past year.
BCAL had a positive operating cash flow in the past year.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.16%, BCAL is doing worse than 92.21% of the companies in the same industry.
With a Return On Equity value of -1.39%, BCAL is not doing good in the industry: 92.21% of the companies in the same industry are doing better.
BCAL has a Return On Invested Capital of 0.96%. This is amongst the best in the industry. BCAL outperforms 99.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BCAL is in line with the industry average of 2.45%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | -1.39% | ||
| ROIC | 0.96% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.51%
ROIC(5y)N/A
1.3 Margins
BCAL's Profit Margin has declined in the last couple of years.
BCAL has a Operating Margin of 40.68%. This is amongst the best in the industry. BCAL outperforms 99.50% of its industry peers.
In the last couple of years the Operating Margin of BCAL has grown nicely.
BCAL does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 40.68% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y19.91%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BCAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BCAL has more shares outstanding
Compared to 1 year ago, BCAL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.83, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
BCAL has a Altman-Z score of -0.83. This is amongst the best in the industry. BCAL outperforms 99.00% of its industry peers.
The Debt to FCF ratio of BCAL is 214.63, which is on the high side as it means it would take BCAL, 214.63 years of fcf income to pay off all of its debts.
BCAL has a worse Debt to FCF ratio (214.63) than 87.94% of its industry peers.
BCAL has a Debt/Equity ratio of 7.65. This is a high value indicating a heavy dependency on external financing.
BCAL has a Debt to Equity ratio of 7.65. This is amonst the worse of the industry: BCAL underperforms 98.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.65 | ||
| Debt/FCF | 214.63 | ||
| Altman-Z | -0.83 |
ROIC/WACC0.26
WACC3.7%
2.3 Liquidity
BCAL has a Current Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
BCAL has a better Current ratio (0.04) than 99.25% of its industry peers.
BCAL has a Quick Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
BCAL has a Quick ratio of 0.04. This is amongst the best in the industry. BCAL outperforms 99.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 |
3. Growth
3.1 Past
BCAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.19%.
The earnings per share for BCAL have been decreasing by -28.36% on average. This is quite bad
Looking at the last year, BCAL shows a very strong growth in Revenue. The Revenue has grown by 45.18%.
BCAL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.61% yearly.
EPS 1Y (TTM)-86.19%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%112.5%
Revenue 1Y (TTM)45.18%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%94.58%
3.2 Future
The Earnings Per Share is expected to grow by 56.82% on average over the next years. This is a very strong growth
BCAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.01% yearly.
EPS Next Y131.01%
EPS Next 2Y56.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.95%
Revenue Next 2Y22.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.75 indicates a rather expensive valuation of BCAL.
78.39% of the companies in the same industry are cheaper than BCAL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.79. BCAL is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 8.12 indicates a reasonable valuation of BCAL.
Based on the Price/Forward Earnings ratio, BCAL is valued cheaper than 80.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. BCAL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 8.12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BCAL is valued cheaply inside the industry as 99.25% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BCAL is valued a bit more expensive than the industry average as 77.14% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.99 | ||
| EV/EBITDA | 6.18 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCAL's earnings are expected to grow with 56.82% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y56.82%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BCAL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
13.69
+0.21 (+1.56%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners56.45%
Inst Owner Change-0.27%
Ins Owners15.93%
Ins Owner Change-0.7%
Market Cap443.56M
Analysts80
Price Target20.4 (49.01%)
Short Float %1.43%
Short Ratio3.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.46%
Min EPS beat(2)-96.35%
Max EPS beat(2)87.43%
EPS beat(4)1
Avg EPS beat(4)-7.83%
Min EPS beat(4)-96.35%
Max EPS beat(4)87.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-2.66%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-4.5%
Min Revenue beat(4)-8.42%
Max Revenue beat(4)-1.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.2%
EPS NY rev (3m)-8.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-4.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.75 | ||
| Fwd PE | 8.12 | ||
| P/S | 2.97 | ||
| P/FCF | 24.99 | ||
| P/OCF | 24.34 | ||
| P/B | 0.89 | ||
| P/tB | 1.22 | ||
| EV/EBITDA | 6.18 |
EPS(TTM)0.73
EY5.33%
EPS(NY)1.69
Fwd EY12.32%
FCF(TTM)0.55
FCFY4%
OCF(TTM)0.56
OCFY4.11%
SpS4.61
BVpS15.37
TBVpS11.19
PEG (NY)0.14
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.16% | ||
| ROE | -1.39% | ||
| ROCE | 10.7% | ||
| ROIC | 0.96% | ||
| ROICexc | 0.98% | ||
| ROICexgc | 1.04% | ||
| OM | 40.68% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 11.9% |
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.51%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.76%
ROCE(5y)N/A
ROICexcg growth 3Y37.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.48%
ROICexc growth 5YN/A
OM growth 3Y19.91%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.65 | ||
| Debt/FCF | 214.63 | ||
| Debt/EBITDA | 60.3 | ||
| Cap/Depr | 19.09% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 1.38 | ||
| Cash Conversion | 28.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.04 | ||
| Quick Ratio | 0.04 | ||
| Altman-Z | -0.83 |
F-Score4
WACC3.7%
ROIC/WACC0.26
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.19%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%112.5%
EPS Next Y131.01%
EPS Next 2Y56.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.18%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%94.58%
Revenue Next Year41.95%
Revenue Next 2Y22.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.71%
EBIT growth 3Y65.01%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-64.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.03%
OCF growth 3YN/A
OCF growth 5YN/A